vindesine has been researched along with Recrudescence in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (15.63) | 18.7374 |
1990's | 11 (34.38) | 18.2507 |
2000's | 11 (34.38) | 29.6817 |
2010's | 4 (12.50) | 24.3611 |
2020's | 1 (3.13) | 2.80 |
Authors | Studies |
---|---|
Chen, FF; Cui, L; Huang, XT; Li, ZG; Lian, HY; Ma, HH; Wang, CJ; Wang, D; Wang, TY; Wei, A; Yang, Y; Zhang, L; Zhang, Q; Zhang, R; Zhu, T | 1 |
Brion, A; Chabin, M; Clavert, A; Colombat, P; Cumin, I; Delwail, V; Escoffre-Barbe, M; Gardembas, M; Ingrand, P; Lacotte-Thierry, L; Legouffe, E; Olivier, G; Solal-Celigny, P | 1 |
Feng, G; Huang, XL; Wan, H; Wang, F; Wang, XJ | 1 |
Gao, XN; Guo, YL; Han, XP; Jin, XS; Jing, Y; Liu, K; Yao, ZL; Yu, L; Zhang, R | 1 |
Cai, HC; Cao, XX; Chen, M; Duan, MH; Han, B; Han, X; Li, J; Wang, SJ; Yang, C; Zhang, W; Zhou, DB; Zhu, TN; Zhuang, JL | 1 |
Egberts, F; Hauschild, A; Hitschler, WN; Weichenthal, M | 1 |
Corbacioglu, S; Eber, S; Gungor, T; Hummerjohann, J; Niggli, F | 1 |
Hinkelbein, W; Hoecht, S | 1 |
Adli, M; Kalender, ME; Sevinc, A | 1 |
Brunot, A; Issler, M; Ojeda-Uribe, M | 1 |
Dibar, E; Eppinger-Helft, M; Garay, G; Kvicala, R; Milone, J; Montres Varela, D; Pavlovsky, S; Sackmann Muriel, F | 1 |
Akabane, T; Hara, T; Koike, K; Komiyama, A; Tsukada, M | 1 |
Conter, V; Jankovic, M; Locasciulli, A; Masera, G; Rossi, MR; Uderzo, C | 1 |
Coiffier, B; Farcet, JP; Gabarre, J; Gastaldi, R; Gisselbrecht, C; Lepage, E; Oksenhendler, E; Raphael, M; Thyss, A; Tirelli, U | 1 |
Kleisbauer, JP; Le Caer, H; Montcharmont, D; Pradal, M; Thomas, P; Vervloet, D | 1 |
Audhuy, B; Blanc, M; Brière, J; Coiffier, B; Diviné, M; Dupriez, B; Herbrecht, R; Lederlin, P; Lepage, E; Mineur, P; Pautier, P; Reyes, F; Tilly, H | 1 |
Ohnishi, K; Ohno, R; Shinjyo, K; Takeshita, A; Tobita, T; Yanagi, M | 1 |
Ariyoshi, Y; Fukuoka, M; Furuse, K; Katagami, N; Kawahara, M; Kudoh, S; Nishikawa, H; Takada, Y | 1 |
Manoharan, A | 1 |
Cazals-Hatem, D; Chevret, S; Clauvel, JP; Dubreuil, ML; Gerard, L; Levy, Y; Matheron, S; Oksenhendler, E | 1 |
Eguchi, K; Harada, M; Kiura, K; Miyamoto, H; Segawa, Y; Shibayama, T; Tabata, M; Takata, I; Takigawa, N; Ueoka, H | 1 |
Daibata, M; Hatakeyama, N; Hiroi, M; Kamioka, M; Miyoshi, I; Nemoto, Y; Taguchi, H | 1 |
Fujitaka, K; Isobe, T; Kagawa, K; Kohno, N; Miyazaki, M; Oguri, T; Yamasaki, M | 1 |
Bilhou-Nabera, C; Boiron, JM; Bouabdallah, R; Boucheix, C; Cazin, B; Charrin, C; Delannoy, A; Dombret, H; Fière, D; Huguet, F; Lhéritier, V; Sebban, C; Straetmans, N; Thomas, X; Vernant, JP; Zérazhi, H | 1 |
Andrien, F; Auzanneau, G; Bosly, A; Coiffier, B; Devaux, Y; Gisselbrecht, C; Herbrecht, R; Jaubert, J; Legros, M; Tilly, H | 1 |
Chisa, M; Hasegawa, S; Katoh, M; Koike, M; Kubomatsu, Y; Kunika, N; Nakamura, K; Sano, F; Takahashi, M; Wakayama, T | 1 |
Bancillon, A; Baruchel, A; Bergeron, C; Leblanc, T; Lejars, O; Lepage, E; Leverger, G; Perel, Y; Schaison, G; Sommelet, D | 1 |
Oguro, M; Sakai, C; Takagi, T | 1 |
Diedrich, H; Freund, M; Ganser, A; Gramatzki, M; Haas, R; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Kuse, R | 1 |
Armand, JP; Benhamed, M; Cvitkovic, E; Domenge, C; Guillot, T; Izzo, J; Recondo, G; Tellez-Bernal, E | 1 |
Kano, Y; Masaoka, T; Mikuni, C; Sakamoto, S; Sampi, K; Takagi, T | 1 |
Akagi, K; Asou, N; Goto, J; Hamasaki, N; Hidaka, M; Kawano, F; Kurisaki, H; Sawatari, T; Suzushima, H; Takatsuki, K | 1 |
10 trial(s) available for vindesine and Recrudescence
Article | Year |
---|---|
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Immunocompetence; Infections; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Palliative Care; Prednisolone; Recurrence; Remission Induction; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Vindesine | 2014 |
Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; L-Lactate Dehydrogenase; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Nerve Growth Factors; Prospective Studies; Recombinant Proteins; Recurrence; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Vindesine | 2009 |
Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse.
Topics: Adolescent; Adult; Anemia; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Leukopenia; Prednisone; Prognosis; Recurrence; Vinblastine; Vindesine | 1983 |
Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; HIV Seropositivity; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Prednisolone; Prospective Studies; Recurrence; Remission Induction; Survival Rate; Vindesine | 1993 |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Prospective Studies; Recurrence; Survival Analysis; Vindesine | 1999 |
Gentle yet effective treatment for elderly patients with refractory or relapsing multiple myeloma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Male; Melphalan; Multiple Myeloma; Prednisolone; Recurrence; Treatment Outcome; Vincristine; Vindesine | 2000 |
Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Recurrence; Survival Analysis; Vindesine | 2000 |
Treatment of acute lymphoblastic leukemia in the elderly: an evaluation of interferon alpha given as a single agent after complete remission.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Humans; Interferon-alpha; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Random Allocation; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine; Vindesine | 2002 |
Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Drug Administration Schedule; Female; France; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Risk Factors; Vincristine; Vindesine | 1992 |
[Aclarubicin-combined combination chemotherapy in patients with refractory or relapsed non-Hodgkin's lymphoma].
Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Drug Resistance; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multicenter Studies as Topic; Prednisolone; Recurrence; Remission Induction; T-Lymphocytes; Vinblastine; Vindesine | 1989 |
22 other study(ies) available for vindesine and Recrudescence
Article | Year |
---|---|
Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: Results from the BCH-LCH 2014 protocol study.
Topics: Child; Child, Preschool; Cladribine; Histiocytosis, Langerhans-Cell; Humans; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome; Vindesine | 2023 |
[Clinical Efficacy of Bleomycin, Cyclophosphamide, Vindesine, Ara-C and Dexamethasone for Treatment of Patients with Relapsed Refractory Diffuse Large B Cell Lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Recurrence; Treatment Outcome; Vincristine; Vindesine | 2015 |
[Imatinib Combined with VP Low Dose Regiment for Treating Newly Diagnosed Adult Patients with Ph-positive ALL].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Fusion Proteins, bcr-abl; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Induction Chemotherapy; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Recurrence; Remission Induction; Transplantation, Homologous; Vindesine | 2015 |
Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study.
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Treatment Outcome; Vindesine; Young Adult | 2016 |
Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Burkitt Lymphoma; Child; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Humans; Immunotherapy; Leukemic Infiltration; Male; Meninges; Methotrexate; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Testis; Topotecan; Transplantation, Autologous; Vindesine | 2003 |
Treatment of localized lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Recurrence; Survival Analysis; Vincristine; Vindesine | 2005 |
Treatment of localized lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Recurrence; Vincristine; Vindesine | 2005 |
[Successful treatment of idiopathic acquired refractory thrombotic thrombocytopenic purpura with an association of rituximab-vindesine. Report of one case].
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Platelet Transfusion; Purpura, Thrombocytopenic, Idiopathic; Purpura, Thrombotic Thrombocytopenic; Recurrence; Rituximab; Treatment Outcome; Vindesine; von Willebrand Factor | 2005 |
[Vindesine plus L-asparaginase and prednisolone therapy (VDS-VLP therapy) for remission induction in children with relapsed acute lymphoblastic leukemia].
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Asparaginase; Child; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphoid; Male; Prednisolone; Recurrence; Vinblastine; Vindesine | 1983 |
[Preliminary data on treatment with Vindesine in relapses of acute lymphoblastic leukemia].
Topics: Child; Humans; Leukemia, Lymphoid; Recurrence; Vinblastine; Vindesine | 1981 |
[Acute bronchospasm due to periwinkle alkaloid and mitomycin association].
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Bronchial Spasm; Bronchodilator Agents; Humans; Middle Aged; Mitomycins; Recurrence; Respiration, Artificial; Spirometry; Vindesine | 1993 |
Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Chi-Square Distribution; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Vindesine | 1996 |
Relapse in the external auditory canal of acute promyelocytic leukemia after treatment with all-trans retinoic acid.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Cytarabine; Daunorubicin; Ear Canal; Female; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Mercaptopurine; Middle Aged; Mitoxantrone; Neoplasm Proteins; Oncogene Proteins, Fusion; Radiotherapy; Recurrence; Remission Induction; Salvage Therapy; Tretinoin; Vindesine | 1997 |
Intensive chemotherapy (LNHIV-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hospitalization; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Treatment Outcome; Vindesine | 2000 |
Detection of human herpesvirus 6 and JC virus in progressive multifocal leukoencephalopathy complicating follicular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain; Cyclophosphamide; DNA, Viral; Doxorubicin; Etoposide; Fatal Outcome; Female; Herpesviridae Infections; Herpesvirus 6, Human; Humans; Immunity, Cellular; Immunocompromised Host; JC Virus; Leukoencephalopathy, Progressive Multifocal; Lymphoma, Follicular; Magnetic Resonance Imaging; Mitoxantrone; Nitrosourea Compounds; Papillomavirus Infections; Piperazines; Polymerase Chain Reaction; Prednisolone; Recurrence; Salvage Therapy; Vincristine; Vindesine; Virus Activation | 2001 |
Syndrome of inappropriate secretion of ADH (SIADH) following cisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Female; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Recurrence; Time Factors; Vindesine | 2001 |
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma; Male; Middle Aged; Multivariate Analysis; Prednisolone; Prognosis; Recurrence; Retrospective Studies; Salvage Therapy; Survival Analysis; Vindesine | 1992 |
[Salvage therapy for recurrent or refractory non-Hodgkin's lymphoma with etoposide, methotrexate, vindesine and prednisolone (EMVP)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Salvage Therapy; Survival Rate; Vindesine | 1992 |
[Combination chemotherapy with mitoxantrone, etoposide, vindesine and prednisolone for relapsed or refractory malignant lymphoma: presence of cross-resistance to CHOP therapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Recurrence; Vincristine; Vindesine | 1992 |
Treatment of relapsed or refractory adult acute lymphocytic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Vindesine | 1992 |
A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Leukocyte Count; Male; Middle Aged; Neutropenia; Recurrence; Remission Induction; Survival Rate; Vindesine | 1990 |
["AB-Triple V" therapy of relapsed or refractory acute myelogenous leukemia].
Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Remission Induction; Vinblastine; Vincristine; Vindesine | 1989 |